The Experts below are selected from a list of 123 Experts worldwide ranked by ideXlab platform

Marilyn A Huestis - One of the best experts on this subject based on the ideXlab platform.

Robin E Choo - One of the best experts on this subject based on the ideXlab platform.

Lauren M Jansson - One of the best experts on this subject based on the ideXlab platform.

Karl B Scheidweiler - One of the best experts on this subject based on the ideXlab platform.

Sara R Jones - One of the best experts on this subject based on the ideXlab platform.

  • effects of the histamine h1 receptor antagonist and benztropine analog Diphenylpyraline on dopamine uptake locomotion and reward
    European Journal of Pharmacology, 2012
    Co-Authors: Erik B Oleson, Jill J Harp, Mark J Ferris, Rodrigo A Espana, Sara R Jones
    Abstract:

    Diphenylpyraline hydrochloride (DPP) is an internationally available antihistamine that produces therapeutic antiallergic effects by binding to histamine H1 receptors. The complete neuropharmacological and behavioral profile of DPP, however, remains uncharacterized. Here we describe studies that suggest DPP may fit the profile of a potential agonist replacement medication for cocaine addiction. Aside from producing the desired histamine reducing effects, many antihistamines can also elicit psychomotor activation and reward, both of which are associated with increased dopamine concentrations in the nucleus accumbens (NAc). The primary aim of this study was to investigate the potential ability of DPP to inhibit the dopamine transporter, thereby leading to elevated dopamine concentrations in the NAc in a manner similar to cocaine and other psychostimulants. The psychomotor activating and rewarding effects of DPP were also investigated. For comparative purposes cocaine, a known dopamine transporter inhibitor, psychostimulant and drug of abuse, was used as a positive control. As predicted, both cocaine (15 mg/kg) and an equimolar dose of DPP (14 mg/kg) significantly inhibited dopamine uptake in the NAc in vivo and produced locomotor activation, although the time-course of pharmacological effects of the two drugs was different. In comparison to cocaine, DPP showed a prolonged effect on dopamine uptake and locomotion. Furthermore, cocaine, but not DPP, produced significant conditioned place preference, a measure of drug reward. The finding that DPP functions as a potent dopamine uptake inhibitor without producing significant rewarding effects suggests that DPP merits further study as a potential candidate as an agonist pharmacotherapy for cocaine addiction.

  • Diphenylpyraline a histamine h1 receptor antagonist has psychostimulant properties
    European Journal of Pharmacology, 2005
    Co-Authors: G B Lapa, Tiffany A Mathews, Jill J Harp, Evgeny A Budygin, Sara R Jones
    Abstract:

    Abstract Diphenylpyraline hydrochloride (DPP) is used clinically as an antihistamine drug, but its neurobiological effects are not completely understood. Voltammetry and microdialysis were used to investigate potential actions of DPP on the dopamine system. Voltammetric monitoring of dopamine signals in mouse nucleus accumbens slices showed that DPP (10 μM) markedly inhibited dopamine uptake. There was a 20-fold increase in apparent Km for dopamine uptake, while Vmax was unchanged. Microdialysis experiments demonstrated that DPP (5 mg/kg, i.p.) elevated extracellular dopamine levels (∼200%) in mouse nucleus accumbens. DPP (5 and 10 mg/kg) also induced locomotor activation. All of the effects of DPP were comparable with those of cocaine. Taken together, these results indicate that DPP acts as a competitive dopamine transporter inhibitor similar to cocaine.